The global cough cold and allergy remedies market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 8.2 billion by 2030. The growth of this market is driven by the increasing prevalence of respiratory diseases, such as asthma and COPD, which are major causes for coughs and colds. The increasing awareness about the benefits of natural remedies for coughs and colds is also driving the growth of this market.
Antihistamines accounted for the largest share in 2017 due to their effectiveness in treating allergic reactions that cause symptoms like sneezing, runny nose, itchy eyes or skin rash. Antihistamines are also used as a treatment for insomnia caused by allergies or other conditions such as anxiety disorders or depression. Expectorants accounted for the second-largest share in 2017 due to their ability to loosen mucus from lungs and throat so that it can be coughed out more easily; they are also used as an expectorant agent in treating bronchitis (a lung infection). Bronchodilators accounted for third-largest share in 2017 due to their ability to relax muscles around airways so that breathing becomes easier; they are also used as a treatment option for asthma patients who experience shortness of breath when exercising or exposed to allergens like pollen or pet dander (animal hair). Decongestants accounted for fourth-largest share in 2017 due to their ability reduce nasal congestion caused by allergies; they are also used as an antihistamine agent with decongestant properties which helps relieve symptoms associated with hay fever (seasonal allergic rhinitis) such as sneezing, runny nose, watery eyes etc, but not all decongestants have antihistamine properties. Antibiotics accounted fifth-largest share in 2017 due because they help fight bacterial infections which may cause symptoms like sore throat, fever etc; antibiotics can be taken orally or applied topically on skin lesions caused by bacteria infections such as acne vulgaris (pimples), impetigo (skin infection), cellulitis (infection under skin) etc, but not all antibiotics have antihistamine properties.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of respiratory diseases such as asthma, COPD, and allergies are driving the growth of the global Cough Cold and Allergy Remedies market.
- Increasing awareness about the benefits of natural remedies for coughs and colds is also driving the growth of this market.
- The increasing number of people suffering from chronic conditions such as asthma, COPD, allergies etc, is also driving this market.
- The increasing demand for over-the-counter (OTC) drugs in developing countries such as India and China is also contributing to this market.
Industry Growth Insights published a new data on “Cough Cold and Allergy Remedies Market”. The research report is titled “Cough Cold and Allergy Remedies Market research by Types (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others, Cough Cold and Allergy Remedie), By Applications (OTC, Rx), By Players/Companies Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble, Cough Cold and Allergy Remedie”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cough Cold and Allergy Remedies Market Research Report
By Type
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others, Cough Cold and Allergy Remedie
By Application
OTC, Rx
By Companies
Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble, Cough Cold and Allergy Remedie
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Cough Cold and Allergy Remedies Market Report Segments:
The global Cough Cold and Allergy Remedies market is segmented on the basis of:
Types
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others, Cough Cold and Allergy Remedie
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
OTC, Rx
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Reckitt Benckiser Group
- Johnson & Johnson
- GlaxoSmithKline
- Novartis
- Bayer
- AstraZeneca
- Sun Pharmaceutical Industries
- Pfizer
- Prestige Brands Holdings
- Procter & Gamble
- Cough Cold and Allergy Remedie
Highlights of The Cough Cold and Allergy Remedies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
- Cough Cold and Allergy Remedie
- By Application:
- OTC
- Rx
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cough Cold and Allergy Remedies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cough cold and allergy remedies are medications that can help to relieve symptoms of a cough or an allergy. These medications may include over-the-counter products, prescription drugs, or natural remedies. Some common cough cold and allergy remedies include decongestants, antihistamines, and nasal sprays.
Some of the major players in the cough cold and allergy remedies market are Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble, Cough Cold and Allergy Remedie.
The cough cold and allergy remedies market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cough Cold and Allergy Remedies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cough Cold and Allergy Remedies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cough Cold and Allergy Remedies Market - Supply Chain
4.5. Global Cough Cold and Allergy Remedies Market Forecast
4.5.1. Cough Cold and Allergy Remedies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cough Cold and Allergy Remedies Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cough Cold and Allergy Remedies Market Absolute $ Opportunity
5. Global Cough Cold and Allergy Remedies Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cough Cold and Allergy Remedies Market Size and Volume Forecast by Type
5.3.1. Antihistamines
5.3.2. Expectorants
5.3.3. Bronchodilators
5.3.4. Decongestants
5.3.5. Antibiotics
5.3.6. Others
5.3.7. Cough Cold and Allergy Remedie
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cough Cold and Allergy Remedies Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cough Cold and Allergy Remedies Market Size and Volume Forecast by Application
6.3.1. OTC
6.3.2. Rx
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cough Cold and Allergy Remedies Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cough Cold and Allergy Remedies Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cough Cold and Allergy Remedies Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cough Cold and Allergy Remedies Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cough Cold and Allergy Remedies Demand Share Forecast, 2019-2026
9. North America Cough Cold and Allergy Remedies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cough Cold and Allergy Remedies Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cough Cold and Allergy Remedies Market Size and Volume Forecast by Application
9.4.1. OTC
9.4.2. Rx
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cough Cold and Allergy Remedies Market Size and Volume Forecast by Type
9.7.1. Antihistamines
9.7.2. Expectorants
9.7.3. Bronchodilators
9.7.4. Decongestants
9.7.5. Antibiotics
9.7.6. Others
9.7.7. Cough Cold and Allergy Remedie
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cough Cold and Allergy Remedies Demand Share Forecast, 2019-2026
10. Latin America Cough Cold and Allergy Remedies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cough Cold and Allergy Remedies Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cough Cold and Allergy Remedies Market Size and Volume Forecast by Application
10.4.1. OTC
10.4.2. Rx
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cough Cold and Allergy Remedies Market Size and Volume Forecast by Type
10.7.1. Antihistamines
10.7.2. Expectorants
10.7.3. Bronchodilators
10.7.4. Decongestants
10.7.5. Antibiotics
10.7.6. Others
10.7.7. Cough Cold and Allergy Remedie
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cough Cold and Allergy Remedies Demand Share Forecast, 2019-2026
11. Europe Cough Cold and Allergy Remedies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cough Cold and Allergy Remedies Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cough Cold and Allergy Remedies Market Size and Volume Forecast by Application
11.4.1. OTC
11.4.2. Rx
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cough Cold and Allergy Remedies Market Size and Volume Forecast by Type
11.7.1. Antihistamines
11.7.2. Expectorants
11.7.3. Bronchodilators
11.7.4. Decongestants
11.7.5. Antibiotics
11.7.6. Others
11.7.7. Cough Cold and Allergy Remedie
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cough Cold and Allergy Remedies Demand Share, 2019-2026
12. Asia Pacific Cough Cold and Allergy Remedies Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cough Cold and Allergy Remedies Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cough Cold and Allergy Remedies Market Size and Volume Forecast by Application
12.4.1. OTC
12.4.2. Rx
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cough Cold and Allergy Remedies Market Size and Volume Forecast by Type
12.7.1. Antihistamines
12.7.2. Expectorants
12.7.3. Bronchodilators
12.7.4. Decongestants
12.7.5. Antibiotics
12.7.6. Others
12.7.7. Cough Cold and Allergy Remedie
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cough Cold and Allergy Remedies Demand Share, 2019-2026
13. Middle East & Africa Cough Cold and Allergy Remedies Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cough Cold and Allergy Remedies Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cough Cold and Allergy Remedies Market Size and Volume Forecast by Application
13.4.1. OTC
13.4.2. Rx
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cough Cold and Allergy Remedies Market Size and Volume Forecast by Type
13.7.1. Antihistamines
13.7.2. Expectorants
13.7.3. Bronchodilators
13.7.4. Decongestants
13.7.5. Antibiotics
13.7.6. Others
13.7.7. Cough Cold and Allergy Remedie
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cough Cold and Allergy Remedies Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Cough Cold and Allergy Remedies Market: Market Share Analysis
14.2. Cough Cold and Allergy Remedies Distributors and Customers
14.3. Cough Cold and Allergy Remedies Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Reckitt Benckiser Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AstraZeneca
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sun Pharmaceutical Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Prestige Brands Holdings
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Procter & Gamble
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cough Cold and Allergy Remedie
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
